| Financial Year |
March 31 2023 |
| Monetary Funds |
7,178,022,921.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,361,479.87 |
| Accounts Receivable |
430,409,786.03 |
| Advances to Suppliers |
29,180,009.67 |
| Other Receivables |
11,526,507.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,200,000.00 |
| Inventories |
109,572,809.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,369,823.39 |
| Total Current Assets |
8,441,714,125.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,099,245,461.53 |
| Investment Properties |
-- |
| Fixed Assetes |
8,780,515,118.52 |
| Under-construction Projects |
497,901,790.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,654,011,063.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,511,964.06 |
| Deferred Income Tax Assets |
190,400,964.55 |
| Other Non-Current Assets |
619,228,036.95 |
| Sub-Total of Non-Current Assets |
15,234,586,127.52 |
| Total Assets |
23,676,300,252.91 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
920,846,323.65 |
| Accounts Received In Advance |
1,809,310.13 |
| Employee Compensation Payable |
202,891,974.36 |
| Taxes Payable |
186,408,572.69 |
| Interest Payable |
-- |
| Dividend Payable |
2,566,958.30 |
| Other payables |
146,969,303.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,127,964.79 |
| Other Current Liabilities |
24,367,566.18 |
| Sub-Total of Current Liabilities |
1,896,107,625.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
192,657,574.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
28,864,864.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
655,935,090.36 |
| Total Liabilities |
2,552,042,715.52 |
| Paid-In Capital(Or Share Stock) |
5,925,928,614.00 |
| Capital Surplus |
3,700,948,692.73 |
| Surplus Reserve |
1,556,830,298.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,281,541,811.43 |
| Minority Stockholder's Interest |
1,400,957,736.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,723,299,800.93 |
| Owner's Equity（Stockholder's Equity） |
21,124,257,537.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,676,300,252.91 |
